You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Self Assembling High Affinity Peptides for Point of Care Drug-Device Combinations

    SBC: AFFINERGY, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Infection surrounding metal implants is a common and sometimes devastating cause of implant failure in a number of fields including oral, craniomaxillofacial (CMF), orthopedic, and cardiovascular surgery. These infectio ns, which arise from the establishment of biofilms on device surfaces, not only necessitate new surgeries but in themselves present a significa ...

    SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  2. Prohealing Coatings for Cardiovascular Implants

    SBC: AFFINERGY, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Summary Improving cardiovascular implants to reduce thrombosis and other confounds has been a long-term goal of medical science. Grafts and endovascular stents have been recently modified to include new materials, atta ched cells or drug-eluting polymers to make them more biocompatible. While these efforts represent substantial progress, the progression from i ...

    SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  3. Bioactive Peptide Coatings for Synthetic Bone Grafts in Dental Applications

    SBC: AFFINERGY, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): According to the National Institute of Dental and Craniofacial Research, 86% of adults over 70 years of age have at least moderate periodontitis with over a quarter having lost their teeth, resulting in serious health a nd quality of life repercussions. Bone grafting is routinely necessary prior to the placement of Dental implants due to bone loss caused by per ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  4. Point of Care Attachment of Antibiotics onto Metal Implants

    SBC: AFFINERGY, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Infection surrounding metal implants is a common and sometimes devastating cause of implant failure in a number of fields including oral, craniomaxillofacial (CMF), orthopedic, and cardiovascular surgery. These infectio ns, which arise from the establishment of biofilms on device surfaces, not only necessitate new surgeries but in themselves present a significa ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  5. Click Chemistry for Immobilized Bone Morphogenetic Protein

    SBC: AFFINERGY, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Growth factors are potent signaling molecules, initiating essential cellular programs for differentiation, proliferation and survival. Only recently have large molecules like growth factors, been employed to enhance the efficacy and specificity of medical implant therapies. In particular, procedures that require native tissues to interact with an implanted mat ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  6. Printed Disposable Sensor for Quantitative HIV RNA Measurement of Viral Load

    SBC: ALDERON BIOSCIENCES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The National Institutes of Allergy and Infectious Disease have called for better tools for the detection and diagnosis of emerging and re-emerging infectious diseases. In response to this need, Alderon Biosciences propo ses research to develop printed disposable sensors for quantification of HIV RNA in resource-poor settings. Our research is important for devel ...

    SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  7. Pseudo Target Amplification Diagnostics

    SBC: ALDERON BIOSCIENCES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The National Institute of Allergy and Infectious Disease has called for better tools for the detection and diagnosis of emerging and re-emerging infectious diseases such as influenza. The need is for tests that are prac tical and affordable for use at point-of-care and near point-of-care settings, such as local public health departments, underdeveloped countrie ...

    SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  8. Innovative Tools for the Molecular Diagnosis of Cancer

    SBC: ALDERON BIOSCIENCES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The National Cancer Institute has called for new tools for cancer research and diagnosis that are accurate, practical and affordable. Alderon Biosciences, Inc. proposes to fill this need by developing an open biosensor platform technology for quantitative studies of cancer gene expression, with the goal of replacing slower and more costly methods. The working ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  9. International Linear Collider Pixel Array Vertex Detector Development

    SBC: American Semiconductor, Inc.            Topic: 52a

    During the past century, physicists have explored subatomic particles in an attempt to understand the fundamental components of the universe, explain the origin of mass, and probe the possibility of an extra-dimensional universe. To advance these explorations, scientists from around the world are working together to develop the International Linear Collider (ILC). ILC applications will require det ...

    SBIR Phase I 2008 Department of Energy
  10. PLATELET-BASED NANOPARTICLE THERAPY FOR PROSTATE CANCER

    SBC: ANDROBIOSYS, INC.            Topic: N/A

    The goal of this proposal is to develop directed energy transfer methods for imaging, tissue ablation and release of therapeutic modalities targeted to the vasculature of prostate cancer. The platform technology is a freeze-dried human platelet (Stasix particles) that contains super paramagnetic iron oxide (SPIO) nanoparticles. The pre-clinical model for validation is the angiogenic human vasculat ...

    SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government